• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETIHX:US

15.76 USD 0.14 0.90%

As of 09:29:30 ET on 04/17/2014.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETIHX)

Year To Date: -3.19% 3-Month: -16.04% 3-Year: - 52-Week Range: 11.65 - 19.94
1-Month: -17.87% 1-Year: +32.21% 5-Year: - Beta vs SPX: -

Mutual Fund Chart for ETIHX

No chart data available.
  • ETIHX:US 15.76
  • 1M
  • 1Y
Interactive ETIHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETIHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETIHX

NAV (on 2014-04-17) 15.76
Assets (M) (on 2014-04-17) 92.08
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 50.00

Dividends for ETIHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETIHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.43

Top Fund Holdings for ETIHX

Filing Date: 12/31/2013
Name Position Value % of Total
Fidelity Institutional Money M 3,105,849 3,105,849 7.814%
Novavax Inc 261,900 1,340,928 3.374%
AtriCure Inc 69,300 1,294,524 3.257%
NPS Pharmaceuticals Inc 38,000 1,153,680 2.903%
Dyax Corp 133,300 1,003,749 2.525%
Ligand Pharmaceuticals Inc 18,200 957,320 2.409%
Puma Biotechnology Inc 9,100 942,123 2.370%
Agios Pharmaceuticals Inc 38,800 929,260 2.338%
Shire PLC 6,400 904,256 2.275%
Tetraphase Pharmaceuticals Inc 65,200 881,504 2.218%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil